Mount Sinai to Lead National Trial of Targeted Therapy for Infants With Noonan Syndrome and Severe Hypertrophic Cardiomyopathy
October 21, 2026
October 21, 2026
NEW YORK, Oct. 21 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
Mount Sinai to Lead National Trial of Targeted Therapy for Infants With Noonan Syndrome and Severe Hypertrophic Cardiomyopathy
*
Researchers at the Icahn School of Medicine at Mount Sinai will lead a new national clinical trial evaluating a precision medicine approach for infants with Noonan syndrome and related conditions who develop . . .
* * *
Mount Sinai to Lead National Trial of Targeted Therapy for Infants With Noonan Syndrome and Severe Hypertrophic Cardiomyopathy
*
Researchers at the Icahn School of Medicine at Mount Sinai will lead a new national clinical trial evaluating a precision medicine approach for infants with Noonan syndrome and related conditions who develop . . .